Careful Administration (OPALMON should be administered with care in the following patients.): Patients with bleeding tendency [Bleeding may be accelerated.].
Patients under treatment with antiplatelet agent, thrombolytic agent or anticoagulant (see Interactions).
Important Precautions: The administration with OPALMON should not be continued aimlessly in patients with lumbar spinal canal stenosis. The progress of symptoms should be observed.
The efficacy of this product has not been established in patients with severe lumbar spinal canal stenosis where operation is judged to be adequate.
Use in Children: The safety of this product in low birth weight infants, neonates, nursing infants, infants or children has not been established (no clinical experience).